Jesus M. Ontoria

1.0k total citations
26 papers, 796 citations indexed

About

Jesus M. Ontoria is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Jesus M. Ontoria has authored 26 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Jesus M. Ontoria's work include Hepatitis C virus research (7 papers), Protein Degradation and Inhibitors (5 papers) and Peptidase Inhibition and Analysis (5 papers). Jesus M. Ontoria is often cited by papers focused on Hepatitis C virus research (7 papers), Protein Degradation and Inhibitors (5 papers) and Peptidase Inhibition and Analysis (5 papers). Jesus M. Ontoria collaborates with scholars based in Italy, United States and Switzerland. Jesus M. Ontoria's co-authors include Michael Rowley, Philip Jones, Carsten Schultz‐Fademrecht, Federica Ferrigno, Rita Scarpelli, Carlo Toniatti, Maria Cecilia Palumbi, Sergio Altamura, Christian Steinkühler and Silvia Pesci and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry.

In The Last Decade

Jesus M. Ontoria

26 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jesus M. Ontoria Italy	18	410	304	287	100	86	26	796
Silvia Pesci Italy	10	195 0.5×	188 0.6×	225 0.8×	40 0.4×	53 0.6×	19	488
Joseph Marakovits United States	10	657 1.6×	349 1.1×	168 0.6×	12 0.1×	177 2.1×	12	1.0k
Hiromasa Hashimoto Japan	14	298 0.7×	54 0.2×	409 1.4×	143 1.4×	113 1.3×	25	828
Guoyi Yan China	14	332 0.8×	125 0.4×	228 0.8×	25 0.3×	32 0.4×	39	608
Sheila Srinivasan United Kingdom	7	185 0.5×	136 0.4×	241 0.8×	14 0.1×	50 0.6×	9	462
Anne Ekker United States	5	146 0.4×	78 0.3×	67 0.2×	119 1.2×	88 1.0×	5	311
Federica Orvieto Italy	11	227 0.6×	79 0.3×	155 0.5×	19 0.2×	129 1.5×	17	440
Thomas Gossas Sweden	14	332 0.8×	40 0.1×	183 0.6×	70 0.7×	71 0.8×	21	583
Thomas Neumann Germany	14	246 0.6×	151 0.5×	68 0.2×	11 0.1×	68 0.8×	41	611
Jean‐Simon Duceppe Canada	15	333 0.8×	83 0.3×	413 1.4×	74 0.7×	103 1.2×	27	679

Countries citing papers authored by Jesus M. Ontoria

Since Specialization

Citations

This map shows the geographic impact of Jesus M. Ontoria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesus M. Ontoria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesus M. Ontoria more than expected).

Fields of papers citing papers by Jesus M. Ontoria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesus M. Ontoria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesus M. Ontoria. The network helps show where Jesus M. Ontoria may publish in the future.

Co-authorship network of co-authors of Jesus M. Ontoria

This figure shows the co-authorship network connecting the top 25 collaborators of Jesus M. Ontoria. A scholar is included among the top collaborators of Jesus M. Ontoria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesus M. Ontoria. Jesus M. Ontoria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferrigno, Federica, Monica Bisbocci, Cristina Alli, et al.. (2024). Direct-to-biology platform: From synthesis to biological evaluation of SHP2 allosteric inhibitors. Bioorganic & Medicinal Chemistry Letters. 100. 129626–129626. 1 indexed citations

Colarusso, Stefania, Federica Ferrigno, Immacolata Conte, et al.. (2022). SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease. Bioorganic & Medicinal Chemistry. 57. 116631–116631. 6 indexed citations

Ferrigno, Federica, Valentina Nardi, Rita Graziani, et al.. (2020). Optimization of 2-(1H-imidazo-2-yl)piperazines series of Trypanosoma brucei growth inhibitors as potential treatment for the second stage of HAT. Bioorganic & Medicinal Chemistry Letters. 30(12). 127207–127207. 1 indexed citations

Ferrigno, Federica, Savina Malancona, Giacomo Paonessa, et al.. (2018). Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3689–3692. 5 indexed citations

Bresciani, Alberto, Jesus M. Ontoria, Antonella Cellucci, et al.. (2018). Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides. ACS Medicinal Chemistry Letters. 10(4). 481–486. 26 indexed citations

Muraglia, Ester, Jesus M. Ontoria, Danila Branca, et al.. (2011). N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists. Bioorganic & Medicinal Chemistry Letters. 21(18). 5283–5288. 17 indexed citations

Malancona, Savina, Monica Donghi, Marco Ferrara, et al.. (2010). Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: Structure-based design and synthesis of new templates. Bioorganic & Medicinal Chemistry. 18(8). 2836–2848. 25 indexed citations

Ontoria, Jesus M., Sergio Altamura, Annalise Di Marco, et al.. (2009). Identification of Novel, Selective, and Stable Inhibitors of Class II Histone Deacetylases. Validation Studies of the Inhibition of the Enzymatic Activity of HDAC4 by Small Molecules as a Novel Approach for Cancer Therapy. Journal of Medicinal Chemistry. 52(21). 6782–6789. 42 indexed citations

Hernando, José Ignacio Martı́n, Jesus M. Ontoria, Savina Malancona, et al.. (2009). Optimization of Thienopyrrole‐Based Finger‐Loop Inhibitors of the Hepatitis C Virus NS5B Polymerase. ChemMedChem. 4(10). 1695–1713. 22 indexed citations

10.

Bisbocci, Monica, Raffaele Ingenito, Jesus M. Ontoria, et al.. (2009). Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1). Bioorganic & Medicinal Chemistry Letters. 20(2). 448–452. 12 indexed citations

11.

Ontoria, Jesus M., Edwin H. Rydberg, Stefania Di Marco, et al.. (2009). Identification and Biological Evaluation of a Series of 1H-Benzo[de]isoquinoline-1,3(2H)-diones as Hepatitis C Virus NS5B Polymerase Inhibitors. Journal of Medicinal Chemistry. 52(16). 5217–5227. 40 indexed citations

12.

Ontoria, Jesus M., Jonathan C. Cruz, Michael Rowley, et al.. (2009). Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model. Bioorganic & Medicinal Chemistry Letters. 19(11). 3081–3084. 26 indexed citations

13.

Orvieto, Federica, Danila Branca, Philip Jones, et al.. (2009). Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(15). 4196–4200. 48 indexed citations

14.

Scarpelli, Rita, Mauro Cerretani, Federica Ferrigno, et al.. (2009). Synthesis and biological evaluation of substituted 2-phenyl-2H-indazole-7-carboxamides as potent poly(ADP-ribose) polymerase (PARP) inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(2). 488–492. 20 indexed citations

15.

Scarpelli, Rita, Annalise Di Marco, Federica Ferrigno, et al.. (2008). Studies of the metabolic stability in cells of 5-(trifluoroacetyl)thiophene-2-carboxamides and identification of more stable class II histone deacetylase (HDAC) inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(23). 6078–6082. 17 indexed citations

16.

Jones, Philip, Matthew J. Bottomley, Andrea Carfı́, et al.. (2008). 2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(11). 3456–3461. 52 indexed citations

17.

Crescenzi, Benedetta, Jesus M. Ontoria, Antonio Marchetti, et al.. (2005). Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part I: Amides and Ureas. Letters in Drug Design & Discovery. 2(6). 451–455. 6 indexed citations

18.

Malancona, Savina, Stefania Colarusso, Jesus M. Ontoria, et al.. (2004). SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease. Bioorganic & Medicinal Chemistry Letters. 14(17). 4575–4579. 20 indexed citations

19.

Nizi, Emanuela, Uwe Koch, Jesus M. Ontoria, et al.. (2004). Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease. Bioorganic & Medicinal Chemistry Letters. 14(9). 2151–2154. 13 indexed citations

20.

Ontoria, Jesus M., et al.. (1999). Synthesis of Two Novel Cyclic Biphenyl Ether Analogs of an Inhibitor of HCV NS3 Protease. Synlett. 1999(Sup. 1). 1000–1002. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact